Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

70
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
70
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

71
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
71
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

86
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-kingdom microbiome interactions along the gut-lung axis: immune-microecological coordination, shared mechanisms, and disease-context dependence in respiratory disorders.

Gut microbes·2026
Same author

Association of Long-Term Oral β-Blocker Use With Cardiac Troponin I and B-Type Natriuretic Peptide in Septic Myocardial Injury: A Retrospective Cohort Study.

Health science reports·2025
Same author

Optimizing Clinical Indicators in Hematologic Malignancies and Sepsis Using ddPCR: A Retrospective Study.

Infectious diseases and therapy·2025
Same author

Status and Prospects of Glioblastoma Multiforme Treatments.

Journal of neurochemistry·2025
Same author

Evolution of ceftazidime-avibactam resistance driven by mutations in double-copy <i>bla</i><sub>KPC-2</sub> to <i>bla</i><sub>KPC-189</sub> during treatment of ST11 carbapenem-resistant <i>Klebsiella pneumoniae</i>.

mSystems·2024
Same author

An Engineered Self-biomineralized Oncolytic Adenovirus Induces Effective Antitumor Immunity and Synergizes With Immune Checkpoint Blockade.

Cancer immunology research·2024

Related Experiment Video

Updated: Sep 8, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
07:03

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Published on: February 15, 2022

1.5K

Panax notoginseng Alleviates Sepsis-Induced Acute Kidney Injury by Reducing Inflammation in Rats.

Di-Wen Shou1, Zi-Lin Yu2,3, Jian-Biao Meng4

  • 1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou 310003, China.

Evidence-Based Complementary and Alternative Medicine : Ecam
|June 14, 2022
PubMed
Summary

Panax notoginseng powder (PNP) protects against sepsis-induced acute kidney injury (AKI) in rats. PNP reduces kidney inflammation and inhibits the NF-κB signaling pathway, improving survival rates.

More Related Videos

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

19.6K
Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

55.2K

Related Experiment Videos

Last Updated: Sep 8, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
07:03

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury

Published on: February 15, 2022

1.5K
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

19.6K
Cecal Ligation Puncture Procedure
11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

55.2K

Area of Science:

  • Pharmacology
  • Nephrology
  • Immunology

Background:

  • Sepsis can lead to end-organ dysfunction, with acute kidney injury (AKI) being a common complication.
  • Panax notoginseng powder (PNP) is known for its anti-inflammatory properties.
  • The protective effect of PNP on septic AKI has not been well-established.

Purpose of the Study:

  • To investigate the protective effects of Panax notoginseng powder (PNP) in a rat model of septic acute kidney injury (AKI).

Main Methods:

  • A cecal ligation and puncture (CLP) model was used to induce septic AKI in male Sprague-Dawley rats.
  • PNP was administered via gavage post-CLP.
  • Kidney and serum samples were analyzed for histopathology, biochemical markers, inflammation, and apoptosis.

Main Results:

  • PNP treatment significantly attenuated kidney injury, reducing histopathological scores.
  • PNP administration lowered elevated serum creatinine and blood urea nitrogen levels.
  • PNP inhibited the expression of pro-inflammatory cytokines (IL-18, IL-1β, TNF-α, IL-6) and the NF-κB signaling pathway in the kidneys.

Conclusions:

  • Panax notoginseng powder (PNP) demonstrates protective effects against sepsis-induced acute kidney injury (AKI) in rats.
  • PNP mitigates kidney inflammation by inhibiting the NF-κB signaling pathway.
  • These findings suggest PNP as a potential therapeutic agent for septic AKI.